MARK2 and hepatocellular carcinoma: Ubiquitin specific peptidase 27 X-linked divergent transcript (USP27X-DT, formerly named USP27X-AS1) was reported to bind with serine and threonine kinase AKT and upregulate AKT signaling in hepatocellular carcinoma [33].